S&P 500   4,629.00 (-0.56%)
DOW   34,830.71 (-0.87%)
QQQ   399.20 (-0.12%)
AAPL   161.87 (+1.02%)
MSFT   335.25 (-0.41%)
FB   334.40 (-1.07%)
GOOGL   2,909.35 (-0.04%)
AMZN   3,564.42 (+0.08%)
TSLA   1,161.92 (+2.19%)
NVDA   330.48 (-0.98%)
BABA   130.66 (-0.72%)
NIO   41.21 (+1.85%)
CGC   10.98 (-0.72%)
AMD   162.82 (+0.56%)
GE   96.05 (-2.39%)
MU   86.17 (+0.03%)
T   23.11 (-3.26%)
F   19.53 (-0.71%)
DIS   146.27 (-1.04%)
ACB   6.50 (+0.93%)
AMC   36.06 (-2.12%)
PFE   53.58 (+2.25%)
BA   195.94 (-1.29%)
S&P 500   4,629.00 (-0.56%)
DOW   34,830.71 (-0.87%)
QQQ   399.20 (-0.12%)
AAPL   161.87 (+1.02%)
MSFT   335.25 (-0.41%)
FB   334.40 (-1.07%)
GOOGL   2,909.35 (-0.04%)
AMZN   3,564.42 (+0.08%)
TSLA   1,161.92 (+2.19%)
NVDA   330.48 (-0.98%)
BABA   130.66 (-0.72%)
NIO   41.21 (+1.85%)
CGC   10.98 (-0.72%)
AMD   162.82 (+0.56%)
GE   96.05 (-2.39%)
MU   86.17 (+0.03%)
T   23.11 (-3.26%)
F   19.53 (-0.71%)
DIS   146.27 (-1.04%)
ACB   6.50 (+0.93%)
AMC   36.06 (-2.12%)
PFE   53.58 (+2.25%)
BA   195.94 (-1.29%)
S&P 500   4,629.00 (-0.56%)
DOW   34,830.71 (-0.87%)
QQQ   399.20 (-0.12%)
AAPL   161.87 (+1.02%)
MSFT   335.25 (-0.41%)
FB   334.40 (-1.07%)
GOOGL   2,909.35 (-0.04%)
AMZN   3,564.42 (+0.08%)
TSLA   1,161.92 (+2.19%)
NVDA   330.48 (-0.98%)
BABA   130.66 (-0.72%)
NIO   41.21 (+1.85%)
CGC   10.98 (-0.72%)
AMD   162.82 (+0.56%)
GE   96.05 (-2.39%)
MU   86.17 (+0.03%)
T   23.11 (-3.26%)
F   19.53 (-0.71%)
DIS   146.27 (-1.04%)
ACB   6.50 (+0.93%)
AMC   36.06 (-2.12%)
PFE   53.58 (+2.25%)
BA   195.94 (-1.29%)
S&P 500   4,629.00 (-0.56%)
DOW   34,830.71 (-0.87%)
QQQ   399.20 (-0.12%)
AAPL   161.87 (+1.02%)
MSFT   335.25 (-0.41%)
FB   334.40 (-1.07%)
GOOGL   2,909.35 (-0.04%)
AMZN   3,564.42 (+0.08%)
TSLA   1,161.92 (+2.19%)
NVDA   330.48 (-0.98%)
BABA   130.66 (-0.72%)
NIO   41.21 (+1.85%)
CGC   10.98 (-0.72%)
AMD   162.82 (+0.56%)
GE   96.05 (-2.39%)
MU   86.17 (+0.03%)
T   23.11 (-3.26%)
F   19.53 (-0.71%)
DIS   146.27 (-1.04%)
ACB   6.50 (+0.93%)
AMC   36.06 (-2.12%)
PFE   53.58 (+2.25%)
BA   195.94 (-1.29%)
NASDAQ:ONCS

OncoSec Medical News Headlines

$1.25
+0.02 (+1.63%)
(As of 11/30/2021 09:51 AM ET)
Add
Compare
Today's Range
$1.23
$1.29
50-Day Range
$1.23
$2.33
52-Week Range
$1.22
$8.16
Volume
5,300 shs
Average Volume
644,567 shs
Market Capitalization
$49.00 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.06

Media Mentions By Week



OncoSec Medical Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ONCS
News Sentiment

0.00

0.27

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ONCS Articles
This Week

0

0

ONCS Articles
Average Week

Get OncoSec Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for ONCS and its competitors with MarketBeat's FREE daily newsletter.

OncoSec Medical (NASDAQ:ONCS) News Headlines Today

SourceHeadline
nasdaq.com logoOncoSec Medical Inc Shares Approach 52-Week Low - Market Mover
nasdaq.com - October 9 at 3:12 AM
finance.yahoo.com logoOncoSec to Participate in Fireside Chat at BTIG Virtual Biotechnology Conference
finance.yahoo.com - August 3 at 9:00 AM
nasdaq.com logoOncoSec Medical Incorporated Common Stock (ONCS)
nasdaq.com - July 27 at 11:20 PM
marketwatch.com logoOncoSec Hikes on Start of Clinical Trial
marketwatch.com - July 7 at 1:14 PM
benzinga.com logoWhy Shares Of OncoSec Medical Are Trading Higher Today
benzinga.com - July 7 at 1:14 PM
finance.yahoo.com logoOncoSec Stock Jumps On Anti-Cancer Gene Therapy Trial Collaboration With Merck In Melanoma
finance.yahoo.com - July 7 at 1:14 PM
finance.yahoo.com logoOncoSec Enters into a Collaboration Agreement with Merck for a Pivotal Global Phase 3 Study, KEYNOTE-C87, of TAVO™ Combined with KEYTRUDA® for Late-Stage Metastatic Melanoma
finance.yahoo.com - July 6 at 7:48 PM
finance.yahoo.com logoOncoSec Appoints Brian Leuthner as Interim Chief Executive Officer
finance.yahoo.com - June 24 at 5:39 PM
finance.yahoo.com logoOncoSec Appoints Industry Leading Electroporation Device Expert, Jeffrey Silverman, as Vice President of Product Engineering
finance.yahoo.com - June 14 at 8:34 AM
finance.yahoo.com logoOncoSec to Present at the Raymond James Human Health Innovation Conference
finance.yahoo.com - May 27 at 9:06 AM
benzinga.com logoOncoSec Aims to Treat Cancer with what the Body Makes Naturally — IL-12
benzinga.com - May 3 at 12:53 PM
nasdaq.com logoHow Much Of OncoSec Medical Incorporated (NASDAQ:ONCS) Do Institutions Own?
nasdaq.com - April 29 at 3:26 PM
seekingalpha.com logoOncoSec receives CE mark certification for its commercial electroporation device
seekingalpha.com - April 16 at 9:24 AM
finance.yahoo.com logoOncoSec to Present Encore Interim Data from the KEYNOTE-695 Phase 2b Clinical Trial at the 10th World Congress of Melanoma
finance.yahoo.com - April 15 at 1:28 PM
finance.yahoo.com logoOncoSec Receives CE Mark Certification for its Commercial Electroporation Device "GenPulse™" for the Treatment of Solid Tumors
finance.yahoo.com - April 14 at 10:34 AM
finance.yahoo.com logoOncoSec Medical Sponsoring KOL Webinar On A High Unmet Medical Need: Anti-PD-1 Checkpoint Refractory Metastatic Melanoma
finance.yahoo.com - April 2 at 8:25 AM
finance.yahoo.com logoOncoSec Announces Publication in Clinical Cancer Research of Data Supporting the Therapeutic Potential of Lead Product Candidate, TAVO™, in Triple Negative Breast Cancer
finance.yahoo.com - March 1 at 10:28 AM
finance.yahoo.com logoOncoSec Announces Approval of $2.5 Million in NJEDA NOL Program Tax Benefits
finance.yahoo.com - February 23 at 12:35 PM
finance.yahoo.com logoOncoSec Appoints Bridget O'Keeffe, Ph.D. as Vice President of Clinical Development
finance.yahoo.com - February 18 at 10:13 AM
finance.yahoo.com logoWhat Type Of Shareholders Own The Most Number of OncoSec Medical Incorporated (NASDAQ:ONCS) Shares?
finance.yahoo.com - February 2 at 2:53 PM
finance.yahoo.com logoOncoSec Strengthens Management Team With Two New Appointments
finance.yahoo.com - February 2 at 2:53 PM
finance.yahoo.com logoOncoSec Announces First Subjects Dosed in Phase 1 Trial of CORVax12, OncoSec's COVID-19 Vaccine Candidate Combining Interleukin-12 (IL-12) with an Enhanced SARS-CoV-2 Spike Protein
finance.yahoo.com - January 27 at 9:15 AM
finance.yahoo.com logoOncoSec Medical Closes $42.0 Million Public Offering of Common Stock
finance.yahoo.com - January 25 at 7:08 PM
finance.yahoo.com logoOncoSec Medical Announces Pricing of $42.0 Million Public Offering of Common Stock
finance.yahoo.com - January 21 at 9:46 AM
finance.yahoo.com logoOncoSec Medical Announces Proposed Public Offering of Common Stock
finance.yahoo.com - January 20 at 8:47 PM
finance.yahoo.com logoOncoSec Enters into Option Agreement with Sirtex Medical to Co-Promote TAVO™
finance.yahoo.com - January 19 at 1:45 PM
finance.yahoo.com logoSirtex Medical announces collaboration update with OncoSec Medical
finance.yahoo.com - January 19 at 1:45 PM
finance.yahoo.com logoCTLT Jan 2021 85.000 call
finance.yahoo.com - January 16 at 8:58 AM
finance.yahoo.com logoOncoSec Announces First Patient Dosed in Phase 2 Trial of TAVO™ Plus OPDIVO® as Neoadjuvant Therapy for Melanoma
finance.yahoo.com - January 8 at 1:10 PM
finance.yahoo.com logoOncoSec Strengthens IP Portfolio with Allowance of Two European Patent Applications Covering TAVO™ and Its Gene Electrotransfer Technology
finance.yahoo.com - December 10 at 9:50 AM
finance.yahoo.com logoOncoSec Announces Publication in International Journal of Surgery Case Reports
finance.yahoo.com - December 3 at 5:54 PM
finance.yahoo.com logoIs OncoSec Medical (ONCS) A Good Stock To Buy Now?
finance.yahoo.com - November 30 at 9:52 PM
nasdaq.com logoOncoSec Secures Rights For Cliniporator Gene Electrotransfer Platform Developed By IGEA
nasdaq.com - November 24 at 10:10 AM
finance.yahoo.com logoOncoSec Announces Exclusive License Agreement for Cliniporator® Gene Electrotransfer Platform Developed by IGEA Clinical Biophysics
finance.yahoo.com - November 24 at 10:10 AM
finance.yahoo.com logoOncoSec Provides Highlights from Analyst & Investor Day and SITC 2020 and Announces KEYNOTE-695 Reaches Full Enrollment
finance.yahoo.com - November 18 at 9:48 AM
seekingalpha.com logoOncoSec: Undervalued And Continuing To Make Progress
seekingalpha.com - November 17 at 11:39 PM
finance.yahoo.com logoOncoSec Announces Positive Interim Data from KEYNOTE-695 Trial in Anti-PD-1 Checkpoint Refractory Metastatic Melanoma at SITC 2020
finance.yahoo.com - November 9 at 9:31 AM
finance.yahoo.com logoOncoSec Hosting an Investor and Analyst Day Webinar Showcasing Positive KEYNOTE-695 Data in Anti-PD-1 Checkpoint Refractory Metastatic Melanoma
finance.yahoo.com - November 5 at 9:29 AM
finance.yahoo.com logoOncoSec to Present Positive Interim Data from KEYNOTE-695 Trial in Anti-PD-1 Checkpoint Refractory Metastatic Melanoma at SITC 2020
finance.yahoo.com - November 3 at 9:25 AM
finance.yahoo.com logoOncoSec Announces FDA Clearance of IND Application for Initiation of Phase 1 Clinical Trial of its CORVax12 Vaccine Candidate for COVID-19
finance.yahoo.com - October 29 at 1:55 PM
nasdaq.com logoOncoSec Announces Appointment of Sandra Aung, Ph.D. as Senior Vice President, Chief Clinical Development Officer
nasdaq.com - October 12 at 11:56 AM
nasdaq.com logoOncoSec Announces Appointment of Sandra Aung, Ph.D. as Senior Vice President, Chief Clinical Development Officer
nasdaq.com - October 12 at 11:56 AM
seekingalpha.com logoOncoSec secures new patent in U.S.; shares up 8%
seekingalpha.com - October 6 at 9:52 AM
finance.yahoo.com logoOncoSec Announces Initiation of a Phase 2 Study at the Moffitt Cancer Center to Evaluate the Combination of TAVO plus OPDIVO® as Neoadjuvant Therapy for Melanoma
finance.yahoo.com - August 27 at 10:33 AM
finance.yahoo.com logoOncoSec to Present at the LD 500 Virtual Conference on September 2, 2020
finance.yahoo.com - August 25 at 10:24 AM
seekingalpha.com logoOncoSec Medical prices $15M-share offering
seekingalpha.com - August 17 at 6:58 AM
finance.yahoo.com logoOncoSec Medical Incorporated Announces Pricing of Public Offering
finance.yahoo.com - August 17 at 6:58 AM
finance.yahoo.com logoOncoSec Prices $15M Offering; Analyst Sees Further 150% Upside Ahead
finance.yahoo.com - August 17 at 6:58 AM
seekingalpha.com logoOncoSec Medical intends to offer common stock
seekingalpha.com - August 16 at 12:48 PM
finance.yahoo.com logoOncoSec Medical Incorporated Announces Proposed Public Offering of Common Stock
finance.yahoo.com - August 14 at 11:44 PM
Get OncoSec Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for ONCS and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 11/30/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.